Fill-finish sites will help Novo Nordisk boost Wegovy, Ozempic output
Novo Nordisk's acquisition of three fill-finish sites will help boost output of its popular Wegovy and Ozempic drugs, the CEO of its parent company Novo Holdings said on Monday. "A key strategic consideration for Novo Nordisk, particularly when thinking about patients and making sure there is…
#novonordisk #wegovyandozempic #novoholdings #ozempicandwegovy #kasimkutay #catalent